Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Boston Scientific (NY:BSX)

61.90 -1.03 (-1.64%)
Streaming Delayed Price Updated: 12:35 PM EDT, Mar 31, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Boston Scientific

< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
News headline image
1 Oversold Stock Ready to Bounce Back and 2 Facing Challenges
Hitting a new 52-week low can be a pivotal moment for any stock. These floors often mark either the beginning of a turnaround story or confirmation that a company faces serious headwinds. 
Via StockStory
News headline image
The 7,800 Frontier: Morgan Stanley Flips the Script with Bullish S&P 500 Forecast
In a dramatic departure from his historically cautious stance, Mike Wilson, Chief U.S. Equity Strategist at Morgan Stanley (NYSE: MS), has stunned Wall Street by raising the firm’s 12-month S&P 500... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
News headline image
Q4 Earnings Highlights: Boston Scientific (NYSE:BSX) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how Boston Scientific (NYSE:BSX)... 
Via StockStory
Boston Scientific Corp (NYSE:BSX) Emerges as a Prime GARP Candidate ↗
Via Chartmill
SNAP, BSX, PYPL Stocks Hit 52-Week Lows — But Refuse To Stay Down After-Hours ↗
Via Stocktwits
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Boston Scientific Corporation - BSX
From Pomerantz LLP
Via GlobeNewswire
News headline image
The Great Unlocking: Medtronic’s Strategic Pivot and the MiniMed Spin-Off
Date: February 24, 2026 By: Financial Research Analyst Introduction For years, Medtronic plc (NYSE: MDT) was viewed by Wall Street as a reliable but sluggish giant—a "Dividend Aristocrat" that offered... 
Via Finterra
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Medtronic Hits 10-Quarter High: PFA Dominance and Robotic Surges Signal a New Era for MedTech
In a definitive sign that the medical technology sector has moved past its post-pandemic stagnation, Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for the third... 
Via MarketMinute
Topics Artificial Intelligence Earnings Economy
Movers and shakers in today's after-hours session for S&P500 stocks? ↗
Via Chartmill
News headline image
ORBIMED Advisors Trims $125 Million Terns Stake After a Breakout Year, According to SEC Filing ↗
Terns Pharmaceuticals has delivered a significant rally over the past year, lifting expectations around its clinical pipeline. The latest filing shifts attention to upcoming data and the company’s... 
Via The Motley Fool
Topics Regulatory Compliance
News headline image
Boston Scientific’s $14.5B Penumbra Mega-Merger: A Strategic Reshaping of the Medtech Landscape
On January 15, 2026, the medical technology sector witnessed its most significant seismic shift in years as Boston Scientific Corporation (NYSE:BSX) announced a definitive agreement to acquire... 
Via MarketMinute
News headline image
Medtronic Hits Ten-Quarter Growth Peak in Q3 Fiscal 2026, Signaling Resurgence in MedTech Sector
Medtronic (NYSE: MDT) reported its strongest enterprise revenue growth in ten quarters for its fiscal third quarter of 2026, marking a significant turning point for the medical technology giant. The... 
Via MarketMinute
Topics Artificial Intelligence Economy World Trade
News headline image
Medtronic (MDT): The Sleeping Giant Awakes with Strong Q3 FY26 Momentum
Today’s Date: February 17, 2026 Introduction Medtronic plc (NYSE: MDT) has long been the sleeping giant of the medical technology sector. For years, the Dublin-domiciled powerhouse was viewed by Wall... 
Via Finterra
Topics Artificial Intelligence Earnings Economy
News headline image
3 S&P 500 Stocks Worth Investigating
The S&P 500 (^GSPC) is packed with companies that have built dominant market positions, making it a core index for investors. A select few continue to innovate and expand, setting themselves up for... 
Via StockStory
Topics Stocks
News headline image
The Top 5 Analyst Questions From Boston Scientific’s Q4 Earnings Call
Boston Scientific’s fourth quarter results were met with a significant negative market reaction, despite meeting revenue expectations and delivering adjusted earnings above analyst consensus.... 
Via StockStory
Topics Earnings
News headline image
Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
From Glancy Prongay Wolke & Rotter LLP
Via Business Wire
News headline image
Pure-Play Pivot: Decoding Becton Dickinson’s (BDX) Q1 Results and the $17.5B Waters Combination
Today, February 9, 2026, marks a watershed moment for Becton, Dickinson and Company (NYSE: BDX). The medical technology giant, commonly known as BD, has officially closed its transformative $17.5... 
Via Finterra
Topics Artificial Intelligence Economy Product Recall
News headline image
3 Safe-and-Steady Stocks to Consider Right Now
Stocks with low volatility can be a great foundation for a portfolio, especially for investors looking to reduce risk. While they don’t often make headlines, these companies provide consistency in an... 
Via StockStory
News headline image
Boston Scientific Corporation (BSX) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
From Law Offices of Howard G. Smith
Via Business Wire
News headline image
Securities Fraud Investigation Into Boston Scientific Corporation (BSX) Announced – Shareholders Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
From The Law Offices of Frank R. Cruz
Via Business Wire
News headline image
The $3.2 Trillion ‘Wall of Capital’: Private Equity Unleashes a Global M&A Renaissance in 2026
As of February 6, 2026, the global financial landscape is being reshaped by an unprecedented "wall of capital." After nearly two years of stagnation caused by valuation gaps and high borrowing costs,... 
Via MarketMinute
Topics Artificial Intelligence Economy Energy
News headline image
The Great Rebound: US M&A Activity Surges 111% as Megadeals Return to Wall Street
The long-awaited "deal drought" has officially broken. As of early February 2026, the American financial landscape is being reshaped by a massive resurgence in corporate deal-making, punctuated by a... 
Via MarketMinute
Topics Artificial Intelligence Economy Government
News headline image
The $14.5 Billion Homecoming: Boston Scientific Reclaims the Neurovascular Throne with Penumbra Acquisition
In a move that has sent shockwaves through the medical technology sector, Boston Scientific (NYSE:BSX) announced on January 15, 2026, a definitive agreement to acquire Penumbra (NYSE:PEN) for... 
Via MarketMinute
Topics Supply Chain
News headline image
Biotech Healthcare: CSDX, NWBO, BSEM, RDGL, NRXBF Emerging Stocks to Watch
Via AB Newswire
Curious about which S&P500 stocks are generating unusual volume on Thursday? Find out below. ↗
Via Chartmill
News headline image
The Return of the Giants: Private Equity Mega-Deals Surge in Early 2026
The "Great Hesitation" in global finance has officially come to an end. In the opening weeks of 2026, the private equity landscape has undergone a dramatic transformation, shifting from two years of... 
Via MarketMinute
Topics Artificial Intelligence Economy Initial Public Offering
News headline image
Navigating the MedTech Correction: A Deep-Dive into Boston Scientific (NYSE: BSX)
February 5, 2026 The medical technology landscape experienced a seismic shift this week as one of its long-standing titans, Boston Scientific (NYSE: BSX), faced a "valuation reset" that has left... 
Via Finterra
Topics Product Recall World Trade
News headline image
BSX Q4 Deep Dive: Growth Engines Face Scrutiny as Market Reacts to Guidance and Segment Dynamics
Medical device company Boston Scientific (NYSE:BSX) met Wall Street’s revenue expectations in Q4 CY2025, with sales up 15.9% year on year to $5.29 billion. The company expects next quarter’s revenue to... 
Via StockStory
Topics Economy World Trade
News headline image
Stock Market Today, Feb. 4: Boston Scientific Plunges After Cautious 2026 Guidance Disappoints Investors ↗
Today, Feb. 4, 2026, investors are weighing Boston Scientific’s guidance against new deals and its long-term margin path. 
Via The Motley Fool
Topics Earnings Stocks
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
26 27 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.